328: Pfizer's activist troubles, gene therapy questions, RFK Jr.'s MAHA ambitions
The Readout Loud
00:00
Catalant Acquisition Controversy
This chapter explores Novo Holdings' attempt to acquire Catalant, highlighting the resulting tensions and opposition from industry players like Roche. It also examines the intricate ownership dynamics between Novo Holdings and Novo Nordisk, and the implications for competition and corporate interests in the pharmaceutical sector.
Transcript
Play full episode
